1AD 5.00% 1.9¢ adalta limited

Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-23

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 10 Posts.
    Solid anouncement again,TO creating alot of avenues in this company,just needs a partnership now for phase two IPF trial and we off to the races,hopefully we can create a base in the mid 3ct range for the moment,good time to accumulate IMO...
 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.